- Leading Researchers and Scientists Detail INOVIO's Proprietary DNA Medicines Technology; Provide Updates on INO-4800 COVID-19 DNA Vaccine and INO-5401 GBM DNA Immunotherapy
- Webinar and Q&A 10 a.m. to Noon EDT on June 1; Registration Information Included
PR Newswire
PLYMOUTH MEETING, Pa., May 26, 2020